Literature DB >> 33893357

A small interfering RNA (siRNA) database for SARS-CoV-2.

Inácio Gomes Medeiros1,2, André Salim Khayat3, Beatriz Stransky4,5, Sidney Santos3, Paulo Assumpção6, Jorge Estefano Santana de Souza7,8.   

Abstract

Coronavirus disease 2019 (COVID-19) rapidly transformed into a global pandemic, for which a demand for developing antivirals capable of targeting the SARS-CoV-2 RNA genome and blocking the activity of its genes has emerged. In this work, we presented a database of SARS-CoV-2 targets for small interference RNA (siRNA) based approaches, aiming to speed the design process by providing a broad set of possible targets and siRNA sequences. The siRNAs sequences are characterized and evaluated by more than 170 features, including thermodynamic information, base context, target genes and alignment information of sequences against the human genome, and diverse SARS-CoV-2 strains, to assess possible bindings to off-target sequences. This dataset is available as a set of four tables, available in a spreadsheet and CSV (Comma-Separated Values) formats, each one corresponding to sequences of 18, 19, 20, and 21 nucleotides length, aiming to meet the diversity of technology and expertise among laboratories around the world. A metadata table (Supplementary Table S1), which describes each feature, is also provided in the aforementioned formats. We hope that this database helps to speed up the development of new target antivirals for SARS-CoV-2, contributing to a possible strategy for a faster and effective response to the COVID-19 pandemic.

Entities:  

Year:  2021        PMID: 33893357     DOI: 10.1038/s41598-021-88310-8

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  53 in total

1.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

Review 2.  The current state and future directions of RNAi-based therapeutics.

Authors:  Ryan L Setten; John J Rossi; Si-Ping Han
Journal:  Nat Rev Drug Discov       Date:  2019-06       Impact factor: 84.694

3.  Alarming COVID variants show vital role of genomic surveillance.

Authors:  David Cyranoski
Journal:  Nature       Date:  2021-01       Impact factor: 49.962

4.  Oral antibiotic therapy for bone and joint infections.

Authors:  C G Prober
Journal:  Pediatr Infect Dis       Date:  1982 Jan-Feb

5.  siRNA-mediated gene silencing in vitro and in vivo.

Authors:  Haibin Xia; Qinwen Mao; Henry L Paulson; Beverly L Davidson
Journal:  Nat Biotechnol       Date:  2002-09-16       Impact factor: 54.908

6.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.

Authors:  R C Lee; R L Feinbaum; V Ambros
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

7.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

8.  Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China.

Authors:  Aiping Wu; Yousong Peng; Baoying Huang; Xiao Ding; Xianyue Wang; Peihua Niu; Jing Meng; Zhaozhong Zhu; Zheng Zhang; Jiangyuan Wang; Jie Sheng; Lijun Quan; Zanxian Xia; Wenjie Tan; Genhong Cheng; Taijiao Jiang
Journal:  Cell Host Microbe       Date:  2020-02-07       Impact factor: 21.023

Review 9.  A review on current status of antiviral siRNA.

Authors:  Abid Qureshi; Vaqar Gani Tantray; Altaf Rehman Kirmani; Abdul Ghani Ahangar
Journal:  Rev Med Virol       Date:  2018-04-15       Impact factor: 6.989

Review 10.  Oligonucleotide antiviral therapeutics: antisense and RNA interference for highly pathogenic RNA viruses.

Authors:  Kevin B Spurgers; C Matthew Sharkey; Kelly L Warfield; Sina Bavari
Journal:  Antiviral Res       Date:  2008-01-14       Impact factor: 5.970

View more
  6 in total

1.  Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread.

Authors:  Shubhankar Ambike; Cho-Chin Cheng; Martin Feuerherd; Stoyan Velkov; Domizia Baldassi; Suliman Qadir Afridi; Diana Porras-Gonzalez; Xin Wei; Philipp Hagen; Nikolaus Kneidinger; Mircea Gabriel Stoleriu; Vincent Grass; Gerald Burgstaller; Andreas Pichlmair; Olivia M Merkel; Chunkyu Ko; Thomas Michler
Journal:  Nucleic Acids Res       Date:  2022-01-11       Impact factor: 16.971

2.  Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors.

Authors:  Jonas Becker; Megan Lynn Stanifer; Sarah Rebecca Leist; Bettina Stolp; Olena Maiakovska; Ande West; Ellen Wiedtke; Kathleen Börner; Ali Ghanem; Ina Ambiel; Longping Victor Tse; Oliver Till Fackler; Ralph Steven Baric; Steeve Boulant; Dirk Grimm
Journal:  Mol Ther       Date:  2022-01-14       Impact factor: 12.910

3.  Selection and Validation of siRNAs Preventing Uptake and Replication of SARS-CoV-2.

Authors:  Maik Friedrich; Gabriele Pfeifer; Stefanie Binder; Achim Aigner; Philippe Vollmer Barbosa; Gustavo R Makert; Jasmin Fertey; Sebastian Ulbert; Jochen Bodem; Eva-Maria König; Nina Geiger; Axel Schambach; Erik Schilling; Tilo Buschmann; Sunna Hauschildt; Ulrike Koehl; Katherina Sewald
Journal:  Front Bioeng Biotechnol       Date:  2022-03-02

4.  Keeping up with the COVID's-Could siRNA-based antivirals be a part of the answer?

Authors:  Helen Forgham; Aleksandr Kakinen; Ruirui Qiao; Thomas P Davis
Journal:  Exploration (Beijing)       Date:  2022-07-14

Review 5.  Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm.

Authors:  Mai Abdel Haleem Abusalah; Moad Khalifa; Mohammad A I Al-Hatamleh; Mu'taman Jarrar; Rohimah Mohamud; Yean Yean Chan
Journal:  J Pers Med       Date:  2022-03-03

Review 6.  Antisense technology as a potential strategy for the treatment of coronaviruses infection: With focus on COVID-19.

Authors:  Seyedeh Hoda Alavizadeh; Maham Doagooyan; Fatemeh Zahedipour; Shima Yahoo Torghabe; Bahare Baharieh; Firooze Soleymani; Fatemeh Gheybi
Journal:  IET Nanobiotechnol       Date:  2022-03-10       Impact factor: 1.847

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.